Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $120.2100 (1.79%) ($116.3300 - $120.8900) on Fri. Feb. 1, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.69% (three month average) | RSI | 37 | Latest Price | $120.2100(1.79%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND advances 0.9% a day on average for past five trading days. | Weekly Trend | LGND declines -2.1% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(60%) IWO(57%) XBI(56%) IWC(54%) IWM(53%) | Factors Impacting LGND price | LGND will decline at least -1.845% in a week (0% probabilities). VXX(-15%) TLT(-15%) VIXM(-10%) UUP(-10%) IFRA(-7%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.845% (StdDev 3.69%) | Hourly BBV | 0 () | Intraday Trend | 1.1% | | | |
|
Resistance Level | $122.97 | 5 Day Moving Average | $117.2(2.57%) | 10 Day Moving Average | $115.75(3.85%) | 20 Day Moving Average | $122.97(-2.24%) | To recent high | -29.8% | To recent low | 9.2% | Market Cap | $1.932b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |